Nov. 05, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) ("BridgeBio” or the "Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that a case ...

Boston is not just a hub for history buffs and sports enthusiasts; it’s also a powerhouse of innovation that propels the ...

But one margin that taxes may affect—innovation—is less frequently considered. Conceptually, taxes reduce the expected net returns to innova-tion inputs and can reduce innovation. Much like other ...

Economic theory does regard capital investment as a contributor to economic growth, but there is another essential factor: ...

This year’s economics award reinforces a comforting but false story about democracy.

In his classic Diffusion of Innovation theory, Everett Rogers found that people are less likely to adopt something new if it doesn’t align well with their prior experience and values.

As we look at the trajectory of enterprise AI near the end of 2024, it seems like the landscape of the industry is becoming more fully baked. And that has some interesting ramifications for all of ...

BridgeBio Pharma, Inc. (NASDAQ: BBIO) shares lost ground at Tuesday’s opening. The Palo Alto, Calif.-based company, which claims to be “a new type of biopharmaceutical company focused on genetic ...

The two species began burying their dead at roughly the same time and place. Now some archaeologists think competition may have played a role in burials.

PharmaReg and MedDevReg AfriSummit host 80+ regional and international speakers alongside over 300 pharmaceutical and medical ...

Stuart Piltch AI Pioneer, a renowned leader in the field of artificial intelligence and technological advancements, continues ...